Vincenzo Quagliariello is an
accomplished researcher who obtained his international PhD in Translational
Medicine in 2015. His research focuses on the biochemistry and pathophysiology
of cancer, with a particular emphasis on nanomedicine as a new tool for cancer
diagnosis and therapy. Since 2016, Vincenzo Quagliariello has been studying the
pathological characteristics of cardiotoxicity induced by anticancer drugs. He
is interested in identifying cardioprotection strategies through drugs or new
formulations, such as nanotechnologies. Vincenzo Quagliariello’s research
specifically analyzes the inflammasome and the cardiac/vascular
microenvironment and their role in cardiotoxicity phenomena. He is also
interested in nutraceuticals, endocrine disruptors exposure, and the study of
the main cardiovascular risk factors in cancer patients.
Research Keywords & Expertise
Inflammation
Nanotechnology
cardio-oncology
chemoresistance
radioresistance
Endocrine disruptor
Fingerprints
19%
Inflammation
10%
cardio-oncology
5%
chemoresistance
5%
Endocrine disruptor
5%
Nanotechnology
Short Biography
Vincenzo Quagliariello is an
accomplished researcher who obtained his international PhD in Translational
Medicine in 2015. His research focuses on the biochemistry and pathophysiology
of cancer, with a particular emphasis on nanomedicine as a new tool for cancer
diagnosis and therapy. Since 2016, Vincenzo Quagliariello has been studying the
pathological characteristics of cardiotoxicity induced by anticancer drugs. He
is interested in identifying cardioprotection strategies through drugs or new
formulations, such as nanotechnologies. Vincenzo Quagliariello’s research
specifically analyzes the inflammasome and the cardiac/vascular
microenvironment and their role in cardiotoxicity phenomena. He is also
interested in nutraceuticals, endocrine disruptors exposure, and the study of
the main cardiovascular risk factors in cancer patients.